the Laka catalogue

no title author date Study on sustainable and resilient supply of medical radioisotopes in the EU. Therapeutic RadionuclidesJoint Research Centre, Ligtvoet, Scholten, Davé, King, Petrosova, Chiti, Goulart De Medeiros, Joerger September 2021 Innovatie in medische isotopenproductie zonder kernreactorLaka, H.vd Keur February 2021 Leveringszekerheid voor medische radionucliden - aanvullingen 2020Roobol, Rosenbaum, de Waard, RIVM December 2020 Marktontwikkeling en leveringszekerheid voor medische radionucliden, aanvullingRoobol, de Waard, RIVM September 2019 Marktontwikkeling en leveringszekerheid voor medische radionucliden Roobol, de Waard, RIVM July 2019 The Supply of Medical Isotopes. An Economic Diagnosis and Possible SolutionsOECD, NEA 2019 European Research Reactor Position Paper. Scenario for sustainable Molybdenum-99 production in EuropeCEA, NCBJ, NRG, PALLAS, RCR, SCK•CEN, TUM June 2018 Marktontwikkeling en leveringszekerheid voor medische isotopenRoobol, de Waard, RIVM April 2018 Medical isotopes. Global importance and opportunities for the Netherlands in a European context Nucleair Nederland November 2017 Medical isotope production using Lighthouse acceleratorJ.W.Blokker November 2017 Productie en gebruik van medische radio-isotopen in Nederland - Huidige situatie en toekomstverkenningRIVM, Roobol, van der Reijden, de Waard–Schalk, Bijwaard July 2017 Cyclotron Based Production of Technetium-99mIAEA June 2017 2017 Medical Isotope Supply Review: Mo/Tc Market Demand and Production Capacity Projection 2017-2022OECD, NEA April 2017 Medische isotopen. Belang voor de wereld en kansen voor NederlandNucleair Nederland April 2017 Molybdenum-99 for Medical ImagingNational Academies of Sciences September 2016 Ruwe schets van de problemen voor de behandeling van Nederlandse patiënten bij een plotselinge productiestop van medische isotopen in NederlandRIVM, Smetsers, Bijwaard, Roobol July 2016 2016 Medical Isotope Supply ReviewNEA June 2016 Emissions from Fission-Based Medical Isotope Production and their Effects on the International Monitoring SystemTh.W.Bowyer May 2015 Feasibility of Producing Molybdenum-99 on a Small Scale Using Fission of Low Enriched Uranium or Neutron Activation of Natural MolybdenumIAEA January 2015 Future Supply of Medical Radioisotopes for the UK Report 2014British Nuclear Medicine Society, Science & Technology Facilities Council November 2014 Nuclear Medicine without Nuclear Reactors or Uranium EnrichmentAAAS, Updegraff, Hoedl May 2013 The Supply of Medical Radioisotopes. Implementation of the HLG-MR Policy Approach. Results from a Self-assessment by the Global 99Mo/99mTc Supply ChainOECD, NEA March 2013 Maximum reasonable radioxenon releases from medical isotope production facilities and their effect on monitoring nuclear explosionsTh.W.Bowyer, R.kephart, P.W.Eslinger, J.Friese September 2012 Working materials Consultancy on Conversion planning for Mo-99 Production facilities from HEU to LEUIAEA August 2010 Isotopic noble gas signatures released from medical isotope production facilities- Simulations and measurementsP.Saey, Th.W.Bowyer, A.Ringbom April 2010 Alternatives for the production of medical isotopesGreenpeace Netherlands, Profundo, J.W.van Gelder, A.Herder March 2010 Report on Molybdenum 99 production for nuclear medicine 2010-2020AIPES November 2008 Patient Dose in Digital Radiology: ICRP Publication 93: Vol.34, No.1ICRP 2004 mit Neutronen fragwürdigKarin Wurzbacher, Umweltinstitut October 2003 Congress of European Association of Nuclear Medicine 23-27 AugustEANM'03 August 2003